Measuring joint movement reliability in children with cerebral palsy
The Influence of Spasticity on Reliability of Range of Movement Measurements for Knee and Ankle in a Pediatric Population With Cerebral Palsy
This study tests how consistently doctors can measure joint movement in children with cerebral palsy to help spot problems early on.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 32 (estimated) |
| Ages | 2 Years to 17 Years |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Lund, Skane) |
| Trial ID | NCT06295107 on ClinicalTrials.gov |
What this trial studies
This study investigates how reliably passive range of motion (pROM) can be measured using a goniometer for knee extension and ankle dorsiflexion in children with unilateral spastic cerebral palsy. It aims to determine the inter-rater reliability of these measurements and to explore the influence of spasticity on this reliability. By using the child as their own control, the study will compare measurements from both spastic and non-spastic limbs. This research is crucial for early detection of joint contractures in affected children.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with unilateral spastic cerebral palsy.
Not a fit: Patients with other types of cerebral palsy or those who have undergone surgery or botulinum toxin treatment within the last three months may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of assessments for joint mobility in children with cerebral palsy, leading to better treatment outcomes.
How similar studies have performed: Previous studies have shown reliability in pROM measurements using goniometers, but this specific investigation into hemiplegic cerebral palsy is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Children with hemiplegic spastic cerebral palsy - Exclusion Criteria: Other cerebral palsy diagnoses. Surgery or botulinum toxin treatment within 3 month prior to examination. -
Where this trial is running
Lund, Skane
- Children Habilitation Unit — Lund, Skane, Sweden (Recruiting)
Study contacts
- Study coordinator: Olof Lindén
- Email: olof.linden@gmail.com
- Phone: +46 46 17 21 69
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.